NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market Thursday that its first quarter revenues climbed 27 percent driven by an uptick in its reproductive health test sales.

The Irvine, California-based molecular diagnostics firm reported total revenues of $3.8 million, up from $3 million in the first quarter of 2016. It noted that its reproductive health test sales were up 32 percent year over year to $2.9 million, while volume for such tests were up 15 percent to 1,642 in the quarter. Its total test volume increased 11 percent year over year to 2,938.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.